Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab

SIMPLE SUMMARY: Elevated serum C-reactive protein (CRP) level is one of the most established markers of systemic inflammation, potentially affecting tumor immune-microenvironmental status. Thus, we assessed the predictive value of serum CRP level for metastatic renal cell carcinoma (mRCC) treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yano, Yusuke, Ohno, Takaya, Komura, Kazumasa, Fukuokaya, Wataru, Uchimoto, Taizo, Adachi, Takahiro, Hirasawa, Yosuke, Hashimoto, Takeshi, Yoshizawa, Atsuhiko, Yamazaki, Shogo, Tokushige, Satoshi, Nishimura, Kazuki, Tsujino, Takuya, Nakamori, Keita, Yamamoto, Shutaro, Iwatani, Kosuke, Urabe, Fumihiko, Mori, Keiichiro, Yanagisawa, Takafumi, Tsuduki, Shunsuke, Takahara, Kiyoshi, Inamoto, Teruo, Miki, Jun, Kimura, Takahiro, Ohno, Yoshio, Shiroki, Ryoichi, Azuma, Haruhito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688397/
https://www.ncbi.nlm.nih.gov/pubmed/36428750
http://dx.doi.org/10.3390/cancers14225659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688397/
https://www.ncbi.nlm.nih.gov/pubmed/36428750
http://dx.doi.org/10.3390/cancers14225659

Ejemplares similares